chartexchange

KROS
Keros Therapeutics, Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 9:31:00 AM EST
11.98USD-0.125%(-0.02)5,956
10.21Bid13.91Ask3.70Spread

KROS Financials

In Q3 FY 2026 (ended ), Keros Therapeutics, Inc. Common Stock (KROS) reported revenue of $40.01M, net income of $14.15M, operating cash flow of $3.39M, and assets of $307.37M (filed ).

Loading financial statements…